Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells - Test2 - elhamkhani - TriplyDB

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

http://www.wikidata.org/entity/Q27487385

about

Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis Natural killer cells in hepatitis C: Current progress Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy Innate immune responses in hepatitis C virus infection (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry MAIT cells are activated during human viral infections Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ Hepatitis C virus RNA functionally sequesters miR-122 Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator Occult infection with hepatitis C virus: friend or foe?Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivity.Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Immune control and failure in HCV infection--tipping the balance.Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.A look behind closed doors: interaction of persistent viruses with dendritic cells.Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.Broadly neutralizing antibodies abrogate established hepatitis C virus infection TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.

P2860

Q21132564-7F378B1D-C56B-441F-8328-97DCB7D538E3 Q26773264-C9DA0763-9082-482F-BC79-BC7137EC43AB Q26778005-3C329D93-C66D-441C-A897-4920EC7B52E4 Q27010312-F2408832-3093-48EA-8889-A2AC044D3582 Q27015778-3D2063C3-9E21-4468-B6AD-34D6423868CD Q27023055-715E1764-B23C-421D-BFCF-E5223AC0BD82 Q27468939-C7804809-FA6C-45E9-8D66-D0F9FDB0E7B1 Q27469032-B7B01B4E-CC75-44C8-A2C2-DBB14AAC5CBF Q27488844-F2C18591-CD06-4D4B-B2C7-D7F6EB23ED04 Q27490169-F447D1C2-1EA3-43FC-B3A2-5747AFAC3CBB Q27490982-FA8F8FE0-7481-4084-9BA1-25FE9A1C0552 Q27491284-296C8DCC-BA38-4DE4-96C0-F13AB1F7B097 Q27491288-81917D35-BCFC-4F9D-AB21-A5EEA44410AC Q27684710-11F577AD-EB9A-4CCD-A6AF-8666A69D9F8E Q27704036-11832860-D1B8-4DB6-A5A3-62A13151FDF6 Q28111713-0415599B-D2F6-481B-B97A-BC3D02324946 Q28476726-6FAEAD21-13FC-464F-BBCC-78F49AA94434 Q30416187-68088B79-2317-43E1-AF15-11B9EC0DC0A7 Q31032919-1476F3B6-0109-467A-89DE-1A278DC0E92E Q33435351-5D53DCCE-2F4B-4FE6-92D7-2B86CF718816 Q33612608-7A2A3843-7CFD-4F92-BA3B-8CC35F4E4222 Q33705274-8A5816B8-D868-41A6-B917-F8A5E69367AF Q33826997-0A04F8BC-ECFB-42B8-A4F2-E22946949E95 Q33883727-11266ED4-93AD-4976-B0AE-B2E4FFF16BA0 Q33922537-649741C9-6F3F-4E54-889E-4D98D13E3AD7 Q33966603-2E91A82F-8BFB-40EA-AAFC-CA75E68A8EA1 Q34074331-027FA536-027C-4D3F-B6F5-3AFEDF2775A1 Q34130213-322FC898-2483-4FC7-A58F-7647B6476D57 Q34178628-EBE61213-AA86-4402-BE05-E68895E1FECB Q34199743-005051F8-4F21-47B6-8AB3-F8B79ADCF755 Q34287407-76DD7614-A0D6-4FF5-A0FF-A65DDF933D5D Q34335916-986D19F1-111C-45B1-A277-50E1504F4FC1 Q34636137-02446656-C4B7-4768-8C5A-3C89FC45C95B Q34692827-1C1DAD7B-333F-47AA-83FB-6DD345965725 Q34697945-58BB0541-81C1-404A-9F02-E6E87E5C04B8 Q34744565-3CFF4276-81B9-440F-A991-DA9ECFB67CAC Q34805086-EBEBF8FF-DD2E-449A-A1E9-4FED871447E0 Q34908895-66293E55-BC3E-4738-BE78-5AB067CD96F4 Q35032263-FD7729DF-F359-47EC-A873-F4E2FB318D96 Q35058574-3B0AF72D-A68E-47E7-A390-B4B2E930FB51

P2860

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

http://www.wikidata.org/entity/Q27487385

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@ast

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@en

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@nl

type

label

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@ast

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@en

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@nl

prefLabel

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@ast

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@en

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@nl

P1433

Q27487385-0CBB53B2-DF3D-496E-8BCE-DBD1C2E943B2

P1476

Q27487385-05E6C1E5-0A8D-4E5B-AA9C-7ADC23AC5B4E

P2093

Q27487385-288FB394-DAF3-453E-B141-7014590A9CFF

Q27487385-360C2592-585C-437A-92B9-AE0D2F4FAAA6

Q27487385-46432F21-042B-44A4-865A-7A31CC94E012

Q27487385-59185D41-DCC0-43E4-A17B-94FD3503C197

Q27487385-6D8485FD-EC58-4373-AADF-040A0BF812F5

Q27487385-74502CB9-6A9E-43DB-A871-C6BD6571667C

Q27487385-AC3380D4-2C07-49CF-8DB2-9DECEE447F96

Q27487385-F5200403-C29A-4CD7-834E-9D1F9BF6E664

P2860

Q27487385-01BF4DF9-607F-45A6-9844-46EEE9F7D7E9

Q27487385-0341DA5E-5992-452A-BDD5-AA7DF9165821

Q27487385-05050E5C-A218-464F-AE2D-D67E9FE73E76

Q27487385-0C4C5410-9B5A-4A8E-9E43-4B1076248255

Q27487385-0CAEE6C0-3828-442A-B7ED-6D69EC8622ED

Q27487385-0D630DFA-9EA3-49EE-A8F3-E470AC34305D

Q27487385-105445C2-31B1-4316-9F2F-F444BC9D9986

Q27487385-10723189-756F-4F5E-87CA-F3B55AB2A296

Q27487385-178F99B4-8E0B-4615-8144-417568BDE844

Q27487385-27E37494-025E-4A2D-8262-D0CEE74325C3

P304

Q27487385-DE10C4EB-D7A9-433A-AB26-B32904E2E182

P31

Q27487385-EEF45DBB-9797-473C-A4C3-C9D55EC552B5

P3181

Q27487385-3C2608A4-5CD7-4618-BF31-6DB8B8994C4C

P356

Q27487385-1D8179EF-CECC-42BB-9E25-0184DF3BEE7F

P407

Q27487385-1DF5E1B2-8C51-4DBD-90AE-46D982397E01

P433

Q27487385-A3711C4F-7731-4266-AB64-AD46561C9954

P478

Q27487385-5407475A-2AC4-4ED2-AB75-429CC1B80786

P577

Q27487385-CE0CE715-5B3E-43F0-BC48-D3D7D2FDD719

P5875

Q27487385-EB2F4A43-FC8D-4B77-B2AE-33E1259D6C34

P698

Q27487385-3DE46A6F-40AA-4F3E-A368-5B9E6B740DB1

P932

Q27487385-6F5F1136-F66D-41AC-B381-F013A9DF9178

P3181

P356

P1433

P1476

Cell culture-produced hepatiti ...... pheral blood mononuclear cells

@en

P2093

Charles M Rice

http://www.w3.org/2001/XMLSchema#string

Christopher T Jones

http://www.w3.org/2001/XMLSchema#string

Edgar D Charles

http://www.w3.org/2001/XMLSchema#string

Kimberly D Ritola

http://www.w3.org/2001/XMLSchema#string

Linda Andrus

http://www.w3.org/2001/XMLSchema#string

Lynn B Dustin

http://www.w3.org/2001/XMLSchema#string

Matthew J Evans

http://www.w3.org/2001/XMLSchema#string

Svetlana Marukian

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

Robust hepatitis C virus infection in vitro.

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

P304

1843-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

554238

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.22550

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23468355

http://www.w3.org/2001/XMLSchema#string

P698

19003912

http://www.w3.org/2001/XMLSchema#string

P932

2592497

http://www.w3.org/2001/XMLSchema#string